Department of Dermatology, Eulji General Hospital, Eulji University, Seoul, Korea.
Division of Endocrinology and Metabolism, Department of Internal Medicine, St Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea.
J Dermatol. 2018 Dec;45(12):1411-1417. doi: 10.1111/1346-8138.14648. Epub 2018 Sep 17.
An association between alopecia areata (AA) and other autoimmune diseases has been reported. We investigated the associations between AA and overt autoimmune thyroid diseases. A nationwide, population-based, cross-sectional study was performed using the Korea National Health Insurance claims database. We defined patients with AA as those whose records showed at least four physician contacts in which AA, alopecia totalis (AT) or alopecia universalis (AU) was the principal diagnosis. We also established an age- and sex-matched control group without AA. In a subgroup analysis, patients with AT or AU were classified into the severe AA group, and the remainder were classified into the mild to moderate AA group. Patients with AA were at an increased risk of Graves' disease (odds ratio [OR], 1.415; 95% confidence interval [CI], 1.317-1.520) and Hashimoto thyroiditis (OR, 1.157; 95% CI, 1.081-1.237), and the associations were stronger in the severe AA group (Graves' disease: OR, 1.714; 95% CI, 1.387-2.118; Hashimoto thyroiditis: OR, 1.398; 95% CI, 1.137-1.719). In conclusion, AA was significantly associated with overt autoimmune thyroid diseases. Furthermore, the risk was much higher in the severe AA group.
斑秃(AA)与其他自身免疫性疾病之间存在关联。我们研究了 AA 与显性自身免疫性甲状腺疾病之间的关联。本项全国性、基于人群的横断面研究使用了韩国国家健康保险索赔数据库。我们将 AA 患者定义为记录中至少有 4 次就诊,其中 AA、全秃(AT)或普秃(AU)是主要诊断的患者。我们还建立了一个无 AA 的年龄和性别匹配对照组。在亚组分析中,将 AT 或 AU 患者分为重度 AA 组,其余患者分为轻中度 AA 组。AA 患者患格雷夫斯病(OR,1.415;95%置信区间 [CI],1.317-1.520)和桥本甲状腺炎(OR,1.157;95% CI,1.081-1.237)的风险增加,且重度 AA 组的关联更强(格雷夫斯病:OR,1.714;95% CI,1.387-2.118;桥本甲状腺炎:OR,1.398;95% CI,1.137-1.719)。总之,AA 与显性自身免疫性甲状腺疾病显著相关。此外,重度 AA 组的风险更高。